Financings in Brief: ThermoGenesis
This article was originally published in The Gray Sheet
Executive Summary
ThermoGenesis: Closes $8.3 mil. private placement managed by Allen & Company. ThermoGenesis says proceeds from the placement will be used to fund development of its two lead products, the CryoSeal autologous surgical sealant and the BioArchive system for processing and storage of blood samples. Rancho Cordova, California-based ThermoGenesis sold 1.7 mil. units in the placement; each unit consisted of two common shares, plus one seven-year warrant to purchase an additional common share...